6Q1 Stock Overview
Provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
Omda AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 2.64 |
| 52 Week High | NOK 3.58 |
| 52 Week Low | NOK 1.95 |
| Beta | 0.57 |
| 11 Month Change | -3.65% |
| 3 Month Change | -12.29% |
| 1 Year Change | -19.02% |
| 33 Year Change | -67.25% |
| 5 Year Change | n/a |
| Change since IPO | -67.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6Q1 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 5.2% | 2.3% | 0.8% |
| 1Y | -19.0% | -31.3% | 9.1% |
Return vs Industry: 6Q1 exceeded the German Healthcare Services industry which returned -32.1% over the past year.
Return vs Market: 6Q1 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 6Q1 volatility | |
|---|---|
| 6Q1 Average Weekly Movement | 7.2% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6Q1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 6Q1's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 295 | Sverre Flatby | www.omda.com |
Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally. The company offers laboratory information management systems consist of CSAM ProSang, a blood, cell, and tissue management system; and medical medication solution comprising CSAM Cytodose, an oncology treatment management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a medical imaging mobile app; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, an patient data transfer tool; Omda Plutus, audit and workflow monitoring platform; Omda S7, a secure e-care communications platform; and Omda XDS, patient data storage and management solution.
Omda AS Fundamentals Summary
| 6Q1 fundamental statistics | |
|---|---|
| Market cap | €49.17m |
| Earnings (TTM) | €7.77m |
| Revenue (TTM) | €35.72m |
6.3x
P/E Ratio1.4x
P/S RatioIs 6Q1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6Q1 income statement (TTM) | |
|---|---|
| Revenue | NOK 416.01m |
| Cost of Revenue | NOK 242.87m |
| Gross Profit | NOK 173.14m |
| Other Expenses | NOK 82.63m |
| Earnings | NOK 90.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.46 |
| Gross Margin | 41.62% |
| Net Profit Margin | 21.76% |
| Debt/Equity Ratio | 848.6% |
How did 6Q1 perform over the long term?
See historical performance and comparison